Project Details

National Coordinator for Aquaculture New Animal Drug Applications, Year 05

July 1, 1999

LocationFundingInstitutionPrincipal Investigator(s)
Hawaii $10,000 Michigan State University R. Schnick, T. Batterson
  1. Coordinate approval activities for amoxicillin, Aqui-S TM, chloramine-T, common carp pituitary, copper sulfate, Earth Tec TM, erythromycin, estrogen, florfenicol, formalin (extension), fumagillin, human chorionic gonadotropin, hydrogen peroxide, 17 alpha-methyltestosterone, Ovaplant TM, Ovaprim TM, oxytetracycline, potassium permanganate, Pyceze TM, sea lice control agents, and trichlorfon.
  2. Implement important provisions of the Minor Use/Minor Species (MUMS) document.
  3. Reduce or eliminate obstacles to approvals of new oral antibacterials (e.g., florfenicol) and maintain current approvals by participating in the coordination and writing of a “white paper” on antimicrobial resistance.
  4. Help harmonize internationally the protocols for susceptibility testing of antimicrobial agents.
  5. Promote international harmonization of aquaculture drug approvals to ensure that pharmaceutical sponsors remain committed to approvals in the United States.